Rivastigmine in Multiple Sclerosis Patients With Cognitive Impairment
Clinical trial NCT00881205 · TERMINATED
Trial details
- NCT number
- NCT00881205
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-04-01
- Primary completion
- 2011-01-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.